CROI 2024 Overall Evaluation Question Title * 1. How did you participate? In-person Virtually Question Title * 2. How have you participated in past CROIs? (Select all that apply.) In person Virtually NA/this is my first CROI Question Title * 3. License(s) or degree(s) (Select all that apply.) MD PhD MD/PhD DO MBBS MBChB PharmD Other (please specify) Question Title * 4. In what country do you reside? Afghanistan Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil British Virgin Island Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands Central African Republic Chad Chile China Colombia Comoros Congo Costa Rica Côte D'Ivoire Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea Bissau Guyana Haiti Holy See Honduras Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka State of Palestine Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Vietnam Yemen Zambia Zimbabwe Question Title * 5. Please select your role at CROI 2024. (Select all that apply.) Presenting Author Coauthor General Attendee Invited Speaker/Moderator/Leader Community Educator Scholarship Awardee External Reviewer Program Committee Member Question Title * 6. What is your primary area of interest at CROI? (Pick one.) Basic science Clinical research Epidemiology Prevention Public health Question Title * 7. Which virus were you most interested in at CROI 2024? (Pick one.) HIV SARS-CoV-2/COVID-19 Hepatitis viruses Monkeypox Other viruses Question Title * 8. Number of years you have been working in the HIV/AIDS field. 0 1-3 4-7 8-12 13-20 21-30 More than 30 Question Title * 9. How many individuals with HIV are presently under your direct care? 1-4 5-10 11-15 16-50 51-100 101-300 301-500 More than 500 None/NA Question Title * 10. Please rate the Opening Session overall. Excellent Very good Good Fair Poor N/A Value in fulfilling the overall learning objectives for the conference Value in fulfilling the overall learning objectives for the conference Excellent Value in fulfilling the overall learning objectives for the conference Very good Value in fulfilling the overall learning objectives for the conference Good Value in fulfilling the overall learning objectives for the conference Fair Value in fulfilling the overall learning objectives for the conference Poor Value in fulfilling the overall learning objectives for the conference N/A Value to your clinical, research, or other responsibility Value to your clinical, research, or other responsibility Excellent Value to your clinical, research, or other responsibility Very good Value to your clinical, research, or other responsibility Good Value to your clinical, research, or other responsibility Fair Value to your clinical, research, or other responsibility Poor Value to your clinical, research, or other responsibility N/A Format of the session Format of the session Excellent Format of the session Very good Format of the session Good Format of the session Fair Format of the session Poor Format of the session N/A Overall freedom of commercial bias Overall freedom of commercial bias Excellent Overall freedom of commercial bias Very good Overall freedom of commercial bias Good Overall freedom of commercial bias Fair Overall freedom of commercial bias Poor Overall freedom of commercial bias N/A Please comment: Question Title * 11. Please rate the Plenaries overall. Excellent Very good Good Fair Poor N/A Value in fulfilling the overall learning objectives for the conference Value in fulfilling the overall learning objectives for the conference Excellent Value in fulfilling the overall learning objectives for the conference Very good Value in fulfilling the overall learning objectives for the conference Good Value in fulfilling the overall learning objectives for the conference Fair Value in fulfilling the overall learning objectives for the conference Poor Value in fulfilling the overall learning objectives for the conference N/A Value to your clinical, research, or other responsibility Value to your clinical, research, or other responsibility Excellent Value to your clinical, research, or other responsibility Very good Value to your clinical, research, or other responsibility Good Value to your clinical, research, or other responsibility Fair Value to your clinical, research, or other responsibility Poor Value to your clinical, research, or other responsibility N/A Format of the plenaries Format of the plenaries Excellent Format of the plenaries Very good Format of the plenaries Good Format of the plenaries Fair Format of the plenaries Poor Format of the plenaries N/A Overall freedom of commercial bias Overall freedom of commercial bias Excellent Overall freedom of commercial bias Very good Overall freedom of commercial bias Good Overall freedom of commercial bias Fair Overall freedom of commercial bias Poor Overall freedom of commercial bias N/A Please comment: Next
